Clinical trials, at first glance, would appear to be an unhurried exercise conducted calmly by lab-coated researchers in sanitised laboratories. The proverbial tip-of-the-iceberg more than adequately describes this situation. In the first place, the planet’s 7.5 billion people are potential consumers of the drugs that undergo clinical trials. Primary targets